DE3787121D1 - Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen. - Google Patents
Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen.Info
- Publication number
- DE3787121D1 DE3787121D1 DE87304827T DE3787121T DE3787121D1 DE 3787121 D1 DE3787121 D1 DE 3787121D1 DE 87304827 T DE87304827 T DE 87304827T DE 3787121 T DE3787121 T DE 3787121T DE 3787121 D1 DE3787121 D1 DE 3787121D1
- Authority
- DE
- Germany
- Prior art keywords
- production
- leukemia virus
- feline leukemia
- virus antigens
- cat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000714165 Feline leukemia virus Species 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 241000282326 Felis catus Species 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86858586A | 1986-05-30 | 1986-05-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3787121D1 true DE3787121D1 (de) | 1993-09-30 |
| DE3787121T2 DE3787121T2 (de) | 1994-04-07 |
Family
ID=25351957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE87304827T Expired - Lifetime DE3787121T2 (de) | 1986-05-30 | 1987-06-01 | Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0247904B1 (de) |
| JP (1) | JP2656521B2 (de) |
| AT (1) | ATE93394T1 (de) |
| AU (1) | AU607427B2 (de) |
| DE (1) | DE3787121T2 (de) |
| DK (1) | DK46988A (de) |
| ES (1) | ES2058113T3 (de) |
| IL (1) | IL82720A0 (de) |
| NZ (1) | NZ220500A (de) |
| PT (1) | PT84976B (de) |
| WO (1) | WO1987007301A1 (de) |
| ZA (1) | ZA873922B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5152982A (en) * | 1984-03-26 | 1992-10-06 | Chiron Corporation | Compositions and methods for FeLV vaccination |
| EP0699758B1 (de) * | 1988-12-13 | 2002-07-24 | President And Fellows Of Harvard College | Prototypische FeLV-Isolate für die Verwendung als Krankheitsmuster oder Impfstoff |
| DK0611397T3 (da) * | 1991-11-08 | 2002-10-07 | Upjohn Co | Vaccine mod katteleukæmivirus |
| GB9210337D0 (en) * | 1992-05-14 | 1992-07-01 | Univ Court Of The University O | Feline leukaemia virus vaccine |
| US6013506A (en) * | 1995-06-05 | 2000-01-11 | Wardley; Richard C. | Feline leukemia virus vaccines |
| US6248582B1 (en) * | 1997-10-08 | 2001-06-19 | Imran Khan | Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| EP1757304A1 (de) | 2005-08-26 | 2007-02-28 | Bundesrepublik Deutschland vertreten durch das Bundesminsterium für Gesundheit, dieses vertr. durch das Robert-Koch-Institut | Pharmazeutische Zusammensetzung, und ihr Verwendung zur prophylaktische und therapeutische Behandlung von retroviralen Krankenheiten |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4406885A (en) * | 1978-12-28 | 1983-09-27 | Research Corporation | Preparation of native oncornavirus envelope subunits and vaccines therefrom |
| US4264587A (en) * | 1979-08-01 | 1981-04-28 | Pedersen Niels C | Vaccine for preventing persistent feline leukemia viremia in cats |
| US4434158A (en) * | 1981-02-11 | 1984-02-28 | Cornell Research Foundation | Cysteine delivery system |
| US4701416A (en) * | 1983-12-09 | 1987-10-20 | Cetus Corporation | Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV |
| EP0156299A3 (de) * | 1984-03-26 | 1987-04-01 | Chiron Corporation | LTR-modifizierte virale Vakzine |
| EP0173997A1 (de) * | 1984-09-06 | 1986-03-12 | Chiron Corporation | Katzenleukämievirusproteinimpfstoffe und ihre Herstellung |
| JPS62501263A (ja) * | 1984-11-29 | 1987-05-21 | スクリツプス クリニツク アンド リサ−チ フアウンデ−シヨン | 脱グリコシル化ウイルス糖タンパク質に関連するポリペプチド類および抗体 |
| AU607399B2 (en) * | 1985-09-09 | 1991-03-07 | Cetus Corporation | Infectious recombinant virus vaccine for feline leukemia |
-
1987
- 1987-05-29 WO PCT/US1987/001278 patent/WO1987007301A1/en unknown
- 1987-05-29 IL IL82720A patent/IL82720A0/xx unknown
- 1987-05-29 AU AU75479/87A patent/AU607427B2/en not_active Expired
- 1987-05-29 PT PT84976A patent/PT84976B/pt not_active IP Right Cessation
- 1987-05-29 JP JP62503637A patent/JP2656521B2/ja not_active Expired - Lifetime
- 1987-05-29 NZ NZ220500A patent/NZ220500A/xx unknown
- 1987-06-01 AT AT87304827T patent/ATE93394T1/de active
- 1987-06-01 DE DE87304827T patent/DE3787121T2/de not_active Expired - Lifetime
- 1987-06-01 ES ES87304827T patent/ES2058113T3/es not_active Expired - Lifetime
- 1987-06-01 EP EP87304827A patent/EP0247904B1/de not_active Expired - Lifetime
- 1987-06-02 ZA ZA873922A patent/ZA873922B/xx unknown
-
1988
- 1988-01-29 DK DK046988A patent/DK46988A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT84976B (pt) | 1990-02-08 |
| DK46988D0 (da) | 1988-01-29 |
| DK46988A (da) | 1988-01-29 |
| JPH01503273A (ja) | 1989-11-09 |
| ES2058113T3 (es) | 1994-11-01 |
| PT84976A (pt) | 1987-06-01 |
| EP0247904A1 (de) | 1987-12-02 |
| ATE93394T1 (de) | 1993-09-15 |
| AU607427B2 (en) | 1991-03-07 |
| EP0247904B1 (de) | 1993-08-25 |
| JP2656521B2 (ja) | 1997-09-24 |
| NZ220500A (en) | 1991-05-28 |
| AU7547987A (en) | 1987-12-22 |
| WO1987007301A1 (en) | 1987-12-03 |
| DE3787121T2 (de) | 1994-04-07 |
| ZA873922B (en) | 1988-02-24 |
| IL82720A0 (en) | 1987-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE249840T1 (de) | Verfahren und materialien zur herstellung von modifizierten variablen antikörperdomänen und ihre therapeutische verwendung | |
| ATE61228T1 (de) | Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff. | |
| ES500567A0 (es) | Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. | |
| DE3750342D1 (de) | Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen. | |
| DE3575520D1 (de) | Rabies-vakzine und verfahren zur herstellung. | |
| DE3773963D1 (de) | Verfahren zur herstellung von reifem, menschlichem serum-albumin. | |
| ATE259878T1 (de) | Verfahren zur verbesserung der immunogenität einer immunogenen zusammensetzung oder eines haptens und verwendung zur herstellung von impfstoffen | |
| DE68915915D1 (de) | Verfahren zur Herstellung von cyclischen Polysiloxanen. | |
| DK163062C (da) | Antigen, immunogen, proteinholdig vaccine imod coccidiose | |
| DE3786832D1 (de) | Verfahren zur herstellung von immunoglobulinzubereitungen fuer intravenoese injektion. | |
| AT364718B (de) | Verfahren zur herstellung neuer muramylpeptid antigen-konjugate | |
| DE58901324D1 (de) | Verfahren zur herstellung von solarsilicium. | |
| DE3766176D1 (de) | Verfahren zur herstellung von tonern. | |
| DE3787121D1 (de) | Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen. | |
| DE3868176D1 (de) | Verfahren zur herstellung von siliciumtetrachlorid. | |
| ATE82985T1 (de) | Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung. | |
| DE3585578D1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
| EP0193585A4 (de) | Kreuzreaktive und schützende epitope von circumsporozoit-proteinen. | |
| DE3787706D1 (de) | Verfahren zur quantitativen Bestimmung der Antigene und Antikörper. | |
| NO883501D0 (no) | Slekt-spesifikt listeria-antigen identifisert med monoklonale antistoffer. | |
| DE3777577D1 (de) | Verfahren zur herstellung von siliziumcarbid-whiskern. | |
| DE3750642D1 (de) | Verfahren und Zusammensetzungen betreffend regressions-assoziierte Antigene. | |
| DE3766046D1 (de) | Verfahren zur herstellung von isopropylakohol und tertiaeren c4-bis c5-alkoholen. | |
| DE3671603D1 (de) | Verfahren zur zucht von babesia canis, verwendung zur herstellung von antigenen und impfstoffen und antigene und impfstoffe gegen piroplasmose. | |
| ATE45500T1 (de) | Verfahren zur herstellung von tuberkulin-l antigen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |